UCFI · Cn Healthy Food Tech Group Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.82M | $7.91M | - | - | - | - | - | - | - | - |
| Cost of Revenue | $2.47M | $1.34M | - | - | - | - | - | - | - | - |
| Gross Profit | $2.36M | $5.57M | - | - | - | - | - | - | - | - |
| R&D | $27.5K | $37.8K | - | - | - | - | - | - | - | - |
| SG&A | $3.07M | $508.5K | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $1.55M | $650.7K | $671.5K | $520.0K | - | $137.1K | $60.3K | $479.9K | - | - |
| D&A | $50.9K | - | - | - | - | - | - | - | - | - |
| Operating Income | $730.6K | $4.58M | ($671.5K) | ($520.0K) | - | ($290.8K) | ($60.3K) | ($479.9K) | - | - |
| Interest Expense | $206.0K | ($10.1K) | - | - | - | - | - | - | - | - |
| Income Tax | $850.5K | $1.38M | $146.2K | $149.2K | - | $187.8K | $178.0K | $211.1K | - | - |
| Net Income | ($309.0K) | $3.34M | ($63.9K) | $83.8K | - | ($137.1K) | ($60.3K) | $473.4K | - | - |
| EPS - Basic | ($0.01) | $0.07 | - | - | - | - | - | - | - | - |
| EPS - Diluted | ($0.01) | $0.07 | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29.69M | $37.21M | $25.2K | $88 | $454 | $3.1K | $91.4K | $179.3K | $657.0K | - |
| Accounts Receivable | $287 | $845 | - | - | - | - | - | - | - | - |
| Inventory | $956.4K | $1.25M | - | - | - | - | - | - | - | - |
| Accounts Payable | $183.3K | $2.06M | $217.7K | $273.7K | $87.6K | - | - | - | - | - |
| Current Assets | $31.36M | $46.18M | $155.0K | $79.7K | $43.5K | $71.3K | $239.5K | $544.2K | $690.1K | - |
| Total Assets | $39.12M | $56.23M | $73.32M | $73.65M | $72.80M | $71.77M | $70.99M | $70.40M | $69.69M | $671.7K |
| Current Liabilities | $19.03M | $38.19M | $72.44M | $3.36M | $2.59M | $1.52M | $1.21M | $1.10M | $861.6K | $847.0K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $19.22M | $38.49M | $74.95M | $5.88M | $5.11M | $4.04M | $3.73M | $3.62M | $3.38M | $847.0K |
| Stockholders' Equity | $19.87M | $17.75M | ($6.11M) | ($4.85M) | ($4.14M) | ($477.4K) | ($340.2K) | ($279.9K) | ($2.69M) | ($175.4K) |
| Retained Earnings | $12.41M | $11.04M | ($6.11M) | ($4.85M) | ($4.14M) | ($3.24M) | ($3.00M) | ($2.81M) | ($2.69M) | ($200.4K) |
Cash Flow
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($3.60M) | - | - | ($409.3K) | - | - | - | ($374.1K) | - | - |
| Investing Cash Flow | ($1.6K) | - | - | ($62.1K) | - | - | - | $3.3K | - | - |
| Financing Cash Flow | $116.0K | - | - | $471.0K | - | - | - | ($106.9K) | - | - |
| CapEx | $73.4K | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | ($3.67M) | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 48.9% | 70.4% | - | - | - | - | - | - | - | - |
| Operating margin | 15.1% | 58.0% | - | - | - | - | - | - | - | - |
| EBITDA margin | 16.2% | - | - | - | - | - | - | - | - | - |
| Net margin | -6.4% | 42.3% | - | - | - | - | - | - | - | - |
| Free cash flow margin | -76.2% | - | - | - | - | - | - | - | - | - |
| FCF / Net income | 11.89 | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 0.6% | 0.5% | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 63.6% | 6.4% | - | - | - | - | - | - | - | - |
| Effective tax rate | 157.1% | 29.2% | 177.7% | 64.0% | - | 370.9% | 151.2% | 30.8% | - | - |
| Return on assets | -0.8% | 5.9% | -0.1% | 0.1% | - | -0.2% | -0.1% | 0.7% | - | - |
| Return on equity | -1.6% | 18.8% | 1.0% | -1.7% | - | 28.7% | 17.7% | -169.1% | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.65 | 1.21 | 0.00 | 0.02 | 0.02 | 0.05 | 0.20 | 0.50 | 0.80 | - |
| Quick ratio | 1.60 | 1.18 | 0.00 | 0.02 | 0.02 | 0.05 | 0.20 | 0.50 | 0.80 | - |
| Cash ratio | 1.56 | 0.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.16 | 0.76 | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 3.5x | -452.1x | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.97 | 3.17 | -12.00 | -15.18 | -17.57 | -150.34 | -208.66 | -251.51 | -25.91 | -3.83 |
| Liabilities / Assets | 0.49 | 0.68 | 1.02 | 0.08 | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 1.26 |
| Efficiency | ||||||||||
| Asset turnover | 0.12 | 0.14 | - | - | - | - | - | - | - | - |
| Inventory turnover | 2.58 | 1.07 | - | - | - | - | - | - | - | - |
| Days sales outstanding | 0d | 0d | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 142d | 340d | - | - | - | - | - | - | - | - |
| Days payable outstanding | 27d | 559d | - | - | - | - | - | - | - | - |
| Cash conversion cycle | 114d | -219d | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | -1013.3% | -8.4% | - | - | - | - | - | - |
| Net income growth (YoY) | - | - | -6.0% | -82.3% | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | -1696.6% | -1633.0% | -54.0% | - | - | - | -1433.9% | - |
Peer comparison
Same SIC group: Food and Kindred Products
Comparing CN Healthy Food Tech Group Corp. against the 5 most active filers in the same SIC group.